{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T01:20:42Z","timestamp":1775438442712,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81271543"],"award-info":[{"award-number":["81271543"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018925","name":"Health Commission of Henan Province","doi-asserted-by":"publisher","award":["LHGJ20200053"],"award-info":[{"award-number":["LHGJ20200053"]}],"id":[{"id":"10.13039\/100018925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>To identify magnetic resonance imaging (MRI) and clinical characteristics that are closely associated with the progression of haemophilic arthropathy (HA) after different therapies and to establish a prediction model for HA progression using Cox proportional hazards regression, thus facilitating the development of personalized clinical replacement therapy plans.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods<\/jats:title>\n            <jats:p>Retrospective clinical and imaging data were collected from HA patients registered at the Henan Provincial Registration Management Center of Haemophilia from December 2010 to May 2023. The inclusion criteria were joints with a history of haemorrhage and initial\/posttreatment reevaluation with X-ray and MRI. Joints with severe damage (i.e., a Pettersson score\u2009&gt;\u20096) were excluded. Joint disease progression was defined as a\u2009&gt;\u20091-point increase in the Pettersson score. Progression-free survival (PFS) was the primary outcome. MRI observations revealed joint effusion, synovial hypertrophy, haemosiderin deposition, bone destruction or cystic degeneration at the joint margins, and cartilage destruction. Age, body mass index (BMI), factor VIII (FVIII) activity, activated partial thromboplastin time (APTT), prothrombin time (PT), therapy type, annual joint bleeding rate (AJBR), and the Haemophilia Joint Health Score (HJHS) were also assessed. Subsequently, univariate and multivariate Cox proportional hazards regression models were employed to analyse the clinical and imaging characteristics influencing HA progression. Factors with a <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.15 in univariate analysis were subsequently included in the multivariate analysis. The impact of various imaging and clinical characteristics on PFS was assessed via Kaplan\u2012Meier (K-M) survival curves.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>This study included 98 joints across 65 patients. During the follow-up period, 63 joints exhibited progression. Both univariate and multivariate Cox analyses revealed that MRI-detected synovial hypertrophy (MRI-SP) was an independent risk factor for HA progression. Incorporating BMI into the model improved its predictive performance (Model 1: c-index\u2009=\u20090.671, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01). Spearman\u2019s correlation analysis revealed strong correlations between baseline MRI-SP and detected haemosiderin deposition (<jats:italic>r<\/jats:italic>\u2009=\u20090.73) as well as AJBRs (<jats:italic>r<\/jats:italic>\u2009=\u20090.66). K-M survival curves indicated that patients receiving prophylactic treatment and those with less severe MRI-SP had better progression-free survival.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>MRI-detected synovial hypertrophy is an independent risk factor for HA progression. The predictive model, which includes BMI as a covariate for assessing the risk of HA progression, can serve as an auxiliary tool for developing personalized treatment plans for HA patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03716-1","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T11:04:16Z","timestamp":1744974256000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The prediction of haemophilic arthropathy progression based on MRI findings and clinical characteristics"],"prefix":"10.1186","volume":"20","author":[{"given":"Lu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinxia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shufang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yincong","family":"Dou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianming","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinghui","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,18]]},"reference":[{"key":"3716_CR1","doi-asserted-by":"crossref","unstructured":"Peyvandi F, Garagiola I, Young G. The past and future of haemophilia: diagnosis, treatments, and its complications[J]. Lancet 2016, 388(10040):187\u201397.","DOI":"10.1016\/S0140-6736(15)01123-X"},{"issue":"1","key":"3716_CR2","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1186\/s13018-023-04409-w","volume":"18","author":"M Bordbar","year":"2023","unstructured":"Bordbar M, Beigipour R, Tahami M, et al. Skeletal complications in patients with hemophilia: a single-center experience[J]. J Orthop Surg Res. 2023;18(1):907.","journal-title":"J Orthop Surg Res"},{"key":"3716_CR3","doi-asserted-by":"crossref","unstructured":"van Vulpen L, Holstein K, Martinoli C. Joint disease in haemophilia: pathophysiology, pain and imaging[J]. Haemophilia, 2018,24 Suppl 6:44\u20139.","DOI":"10.1111\/hae.13449"},{"key":"3716_CR4","doi-asserted-by":"crossref","unstructured":"Chozie NA, Primacakti F, Gatot D et al. Comparison of the efficacy and safety of 12-month low-dose factor VIII tertiary prophylaxis vs on-demand treatment in severe haemophilia A children[J]. Haemophilia, 2019, 25(4):633\u20139.","DOI":"10.1111\/hae.13770"},{"issue":"5","key":"3716_CR5","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.jtha.2023.01.035","volume":"21","author":"FHP van Leeuwen","year":"2023","unstructured":"van Leeuwen FHP, van Bergen EDP, Timmer MA, et al. Magnetic resonance imaging evidence for subclinical joint bleeding in a Dutch population of people with severe hemophilia on prophylaxis[J]. J Thromb Haemost. 2023;21(5):1156\u201363.","journal-title":"J Thromb Haemost"},{"key":"3716_CR6","doi-asserted-by":"crossref","unstructured":"Majeed H, Ahmed H, Sussman MS et al. Understanding early hemophilic arthropathy in children and adolescents through MRI T2 Mapping[J]. J Magn Reson Imaging 2021, 53(3):827\u201337.","DOI":"10.1002\/jmri.27406"},{"key":"3716_CR7","doi-asserted-by":"crossref","unstructured":"Mahlangu J, Oldenburg J, Paz-Priel I et al. Emicizumab prophylaxis in patients who have hemophilia A without Inhibitors[J]. N Engl J Med 2018, 379(9):811\u201322.","DOI":"10.1056\/NEJMoa1803550"},{"issue":"21","key":"3716_CR8","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1056\/NEJMoa2104205","volume":"385","author":"LA George","year":"2021","unstructured":"George LA, Monahan PE, Eyster ME, et al. Multiyear factor VIII expression after AAV gene transfer for hemophilia A[J]. N Engl J Med. 2021;385(21):1961\u201373.","journal-title":"N Engl J Med"},{"key":"3716_CR9","doi-asserted-by":"crossref","unstructured":"Spasov N, Dimitrova-Popova D, Traikova-Djambazova N et al. Magnetic resonance imaging of hemophilic joints: correlations with the bleeding phenotype and physical Examination[J]. Folia Med (Plovdiv), 2020, 62(4):762\u20138.","DOI":"10.3897\/folmed.62.e50550"},{"key":"3716_CR10","doi-asserted-by":"crossref","unstructured":"Pettersson H, Ahlberg A, Nilsson IM. A radiologic classification of hemophilic arthropathy[J]. Clin Orthop Relat Res 1980, 149(149):153\u20139.","DOI":"10.1097\/00003086-198006000-00018"},{"key":"3716_CR11","doi-asserted-by":"crossref","unstructured":"Sun J, Hilliard PE, Feldman BM, et al. Chinese hemophilia joint health score 2.1 reliability study[J]. Volume 20. Haemophilia; 2014. pp. 435\u201340. 3.","DOI":"10.1111\/hae.12330"},{"key":"3716_CR12","doi-asserted-by":"crossref","unstructured":"Lundin B, Manco-Johnson ML, Ignas DM et al. An MRI scale for assessment of haemophilic arthropathy from the international prophylaxis study Group[J]. Haemophilia, 2012, 18(6):962\u201370.","DOI":"10.1111\/j.1365-2516.2012.02883.x"},{"issue":"2","key":"3716_CR13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1158\/2326-6066.CIR-13-0163","volume":"2","author":"J Yuan","year":"2014","unstructured":"Yuan J, Zhou J, Dong Z, et al. Pretreatment serum VEGF is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumab. CANCER IMMUNOL RES. 2014;2(2):127\u201332.","journal-title":"CANCER IMMUNOL RES"},{"issue":"3","key":"3716_CR14","doi-asserted-by":"publisher","first-page":"e227","DOI":"10.1111\/hae.12394","volume":"20","author":"R Wu","year":"2014","unstructured":"Wu R, Wu X, Zhang N, et al. Joint disease status of severe and moderate haemophilia patients at the Beijing children\u2019s hospital: early onset and rapid increasing severity of arthropathy in 90% of patients by 6 years of age. Haemophilia. 2014;20(3):e227\u201330. https:\/\/doi.org\/10.1111\/hae.12394.","journal-title":"Haemophilia"},{"issue":"8","key":"3716_CR15","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1182\/blood-2011-01-327312","volume":"117","author":"T Abshire","year":"2011","unstructured":"Abshire T. Unraveling hemophilic arthropathy[J]. Blood. 2011;117(8):2302\u20133.","journal-title":"Blood"},{"issue":"6","key":"3716_CR16","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1056\/NEJMoa067659","volume":"357","author":"MJ Manco-Johnson","year":"2007","unstructured":"Manco-Johnson MJ, Abshire TC, Shapiro AD, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia[J]. N Engl J Med. 2007;357(6):535\u201344.","journal-title":"N Engl J Med"},{"key":"3716_CR17","doi-asserted-by":"crossref","unstructured":"Zhu H, Meng Y, Tong P et al. Pathological mechanism of joint destruction in haemophilic arthropathy[J]. Mol Biol Rep 2021, 48(1):969\u201374.","DOI":"10.1007\/s11033-020-06052-8"},{"issue":"12","key":"3716_CR18","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1111\/jth.13518","volume":"14","author":"T Manonjensen","year":"2016","unstructured":"Manonjensen T, Karsdal MA, Nielsen LN, et al. Altered collagen turnover in factor VIII-deficient rats with hemophilic arthropathy identifies potential novel serological biomarkers in hemophilia[J]. J Thromb Haemostasis Jth. 2016;14(12):2419\u201329.","journal-title":"J Thromb Haemostasis Jth"},{"issue":"2","key":"3716_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/jth.12101","volume":"11","author":"D Sen","year":"2013","unstructured":"Sen D, Chapla A, Walter N, et al. Nuclear factor (NF)-\u03ba B and its associated pathways are major molecular regulators of blood-induced joint damage in a murine model of hemophilia[J]. J Thromb Haemost. 2013;11(2):293\u2013306.","journal-title":"J Thromb Haemost"},{"key":"3716_CR20","doi-asserted-by":"crossref","unstructured":"Zhou JY, Wong JH, Berman ZT et al. Bleeding with iron deposition and vascular remodelling in subchondral cysts: A newly discovered feature unique to haemophilic arthropathy[J]. Haemophilia, 2021, 27(6): e730\u20138.","DOI":"10.1111\/hae.14417"},{"key":"3716_CR21","doi-asserted-by":"crossref","unstructured":"Fei-Qiu Wen AA, Jabbar Y-X, Chen et al. C-Myc proto-oncogene expression in hemophilic synovitis: in vitro studies of the effects of iron and ceramide[J]. Blood, 2002, 100(3):12\u2013916.","DOI":"10.1182\/blood-2002-02-0390"},{"key":"3716_CR22","doi-asserted-by":"crossref","unstructured":"Adams E, Deutsche J, Okoroh E et al. An inventory of healthy weight practices in federally funded haemophilia treatment centres in the united States[J]. Haemophilia, 2014, 20(5):639\u201343.","DOI":"10.1111\/hae.12385"},{"issue":"1","key":"3716_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13075-018-1575-2","volume":"20","author":"E Rydell","year":"2018","unstructured":"Rydell E, Forslind K, Nilsson JA, et al. Smoking, body mass index, disease activity, and the risk of rapid radiographic progression in patients with early rheumatoid arthritis[J]. Arthritis Res Ther. 2018;20(1):82.","journal-title":"Arthritis Res Ther"},{"key":"3716_CR24","doi-asserted-by":"crossref","unstructured":"Tolend M, Majeed H, Soliman M et al. Critical appraisal of the international prophylaxis study group magnetic resonance image scale for evaluating haemophilic arthropathy[J]. Haemophilia: Official J World Federation Hemophilia 2020, 26(4):565\u201374.","DOI":"10.1111\/hae.14032"},{"issue":"6","key":"3716_CR25","doi-asserted-by":"publisher","first-page":"e12552","DOI":"10.1002\/rth2.12552","volume":"5","author":"R Wu","year":"2021","unstructured":"Wu R, Li X, Yao W, et al. Significant reduction in hemarthrosis in boys with severe hemophilia A: the China hemophilia individualized low-dose secondary prophylaxis study. Res Pract Thromb Haemost. 2021;5(6):e12552. https:\/\/doi.org\/10.1002\/rth2.12552.","journal-title":"Res Pract Thromb Haemost"},{"key":"3716_CR26","doi-asserted-by":"crossref","unstructured":"Song X, Zhong J, Xue F et al. An overview of patients with haemophilia A in China: epidemiology, disease severity and treatment strategies[J]. Haemoph 2020, 1(27):51\u20139.","DOI":"10.1111\/hae.14217"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03716-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03716-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03716-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T11:04:22Z","timestamp":1744974262000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03716-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,18]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3716"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03716-1","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,18]]},"assertion":[{"value":"30 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethics Committee of Henan Provincial People\u2019s Hospital (Approval No. 2017-No. 49).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from the participants or their legal guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"190"}}